3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32800831 | Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. | 2020 Oct 15 | 1 |
2 | 31483932 | Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin. | 2019 Dec | 1 |
3 | 19628748 | ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. | 2010 Jan | 4 |